RE: RNS - good update on progress & prospects8 Dec 2020 08:07
Overview - very positive on all key metrics
Resilient trading performance delivering year-on-year revenue growth despite Covid-19 pandemic (FY19: £7.3m)
Total contract value ("TCV") signed up 97% against FY19, reflecting early successes in prioritising multi-year deals across both new and existing customers
Trading EBITDA1, a key marker for demonstrating the success of the Group's recovery to date, expected to be well ahead in H2 of the £68k achieved in H1 (FY19: loss of £235k),
Substantial cost optimisation phases complete, with trading overheads reduced
Cash positive in FY20 following decrease of £1.1m in FY19 (the Group has made use of government financial support schemes such as furlough and VAT deferral)